User profiles for Jeremy Swann

Jeremy Swann

UK Atomic Energy Authority
Verified email at ukaea.uk
Cited by 1208

[HTML][HTML] Immune surveillance of tumors

JB Swann, MJ Smyth - The Journal of clinical investigation, 2007 - Am Soc Clin Investig
The ability of the immune system to identify and destroy nascent tumors, and to thereby
function as a primary defense against cancer, has been debated for many decades. Recent …

Adaptive immunity maintains occult cancer in an equilibrium state

CM Koebel, W Vermi, JB Swann, N Zerafa, SJ Rodig… - Nature, 2007 - nature.com
The capacity of immunity to control and shape cancer, that is, cancer immunoediting, is the
result of three processes 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 that function either independently or in …

[HTML][HTML] Elephant shark genome provides unique insights into gnathostome evolution

…, AP Lee, V Ravi, AK Maurya, MM Lian, JB Swann… - Nature, 2014 - nature.com
The emergence of jawed vertebrates (gnathostomes) from jawless vertebrates was accompanied
by major morphological and physiological innovations, such as hinged jaws, paired …

Immune-mediated dormancy: an equilibrium with cancer

MWL Teng, JB Swann, CM Koebel… - Journal of Leucocyte …, 2008 - academic.oup.com
This brief review discusses the role of the immune system in tumor development, covering a
history of cancer immunity and a summary of the concept of cancer immunoediting, …

[HTML][HTML] A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor γ deficiency

CR Walkley, GH Olsen, S Dworkin, SA Fabb, J Swann… - Cell, 2007 - cell.com
Myeloproliferative syndromes (MPS) are a heterogeneous subclass of nonlymphoid hematopoietic
neoplasms which are considered to be intrinsic to hematopoietic cells. The causes of …

CD4+ CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer

MJ Smyth, MWL Teng, J Swann… - The Journal of …, 2006 - journals.aai.org
CD4+ CD25+ regulatory T cells (Treg) that suppress T cell-mediated immune responses
may also regulate other arms of an effective immune response. In particular, in this study we …

Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis

JB Swann, MD Vesely, A Silva… - Proceedings of the …, 2008 - National Acad Sciences
Here we report the effects of loss of the Toll-like receptor-associated signaling adaptor
myeloid-differentiation factor 88 (MyD88) on tumor induction in two distinct mouse models of …

Type I IFN contributes to NK cell homeostasis, activation, and antitumor function

JB Swann, Y Hayakawa, N Zerafa… - The Journal of …, 2007 - journals.aai.org
This study demonstrates that type I IFNs are an early and critical regulator of NK cell numbers,
activation, and antitumor activity. Using both IFNAR1-and IFNAR2-deficient mice, as well …

NKG2D function protects the host from tumor initiation

MJ Smyth, J Swann, E Cretney, N Zerafa… - The Journal of …, 2005 - rupress.org
The activation NKG2D receptor has been shown to play an important role in the control of
experimental tumor growth and metastases expressing ligands for NKG2D; however, a …

Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational study

…, J Kavanagh, KK Chau, PW Fowler, J Swann… - elife, 2020 - elifesciences.org
We conducted voluntary Covid-19 testing programmes for symptomatic and asymptomatic
staff at a UK teaching hospital using naso-/oro-pharyngeal PCR testing and immunoassays for …